The upregulation of PHF19 in cancers correlates with increased immune cell infiltration, particularly of myeloid-derived suppressor cells and Th2 subsets of CD4+ T cells, which may contribute to the immune evasion mechanisms of tumors. This evidence concerns the gene PHF19 and cancer.